Posts by Blake Kenney

What’s New in PET/CT Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in restaging and prognosis of recurrent melanoma after curative surgery. PET/CT Updates, Research & Education May 2019 Malignant melanoma is a highly aggressive tumor and surgical resection is the primary treatment. However, the chances of recurrence are quite high despite complete resection. The aim…

What’s New in PET/CT Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation. PET/CT Updates, Research & Education April 2019 Purpose To evaluate the prognostic value of metabolic parameters of pre-treatment and interim 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for overall survival (OS) of esophageal cancer(EC) patients…

What’s New in PET/CT The significant value of predicting prognosis in patients with colorectal cancer using 18F-FDG PET metabolic parameters of primary tumors and hematological parameters. PET/CT Updates, Research & Education March 2019 Purpose The purpose was to evaluate the correlation of the pre-treatment hematological parameters with metabolic parameters of primary tumor in baseline 18F-FDG…

What’s New in PET/CT What’s known about cancer prevention is still evolving. However, it’s well-accepted that your chances of developing cancer are affected by the lifestyle choices you make. PET/CT Updates, Research & Education February 2019 Consider these cancer-prevention tips: 1. Don’t use tobaccoSmoking has been linked to various types of cancer — including cancer…

What’s New in PET/CT Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer. PET/CT Updates, Research & Education January 2019 Purpose The aim of this study was to investigate the value of five typical fluorine-18-fluorodeoxyglucose PET/computed tomography (CT) parameters (including SUVmax, SUVmean, SUVpeak, MTV and TLG) in…

What’s New in PET/CT Total FDG lesion number on PET/CT predicts survival of esophageal carcinoma patients with recurrence following curative surgery. PET/CT Updates, Research & Education December 2018 Purpose Total lesion number is a prognostic determinant in recurrent esophageal cancer, but this requires multiple tests. Here, we investigated the prognostic value of total FDG lesion…

What’s New in PET/CT Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer. PET/CT Updates, Research & Education November 2018 Purpose The standard treatment for patients with stage III non-small cell lung cancer (NSCLC), unsuitable for resection and with good performance, is definitive…

What’s New in PET/CT 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men. PET/CT Updates, Research & Education October 2018 Purpose 18F-FDG PET/CT has demonstrated substantial value in systemic staging of newly diagnosed breast cancer in women. However, it is not known whether breast cancer in male patients benefit similarly. This study…